TDS Pharm Co (XKRX:464280) Accounts Payable & Accrued Expense : ₩2,573 Mil (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is TDS Pharm Co Accounts Payable & Accrued Expense?

TDS Pharm Co's quarterly accounts payable & accrued expense declined from Sep. 2024 (₩4,502 Mil) to Dec. 2024 (₩3,514 Mil) and declined from Dec. 2024 (₩3,514 Mil) to Mar. 2025 (₩2,573 Mil).

TDS Pharm Co's annual accounts payable & accrued expense increased from Dec. 2022 (₩3,555 Mil) to Dec. 2023 (₩3,648 Mil) but then declined from Dec. 2023 (₩3,648 Mil) to Dec. 2024 (₩3,514 Mil).

TDS Pharm Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for TDS Pharm Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TDS Pharm Co Accounts Payable & Accrued Expense Chart

TDS Pharm Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

2,100.84

2,407.39

3,555.39

3,648.35

3,514.37

TDS Pharm Co Quarterly Data
	Dec20	Dec21	Dec22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial					3,648.35	3,359.00	4,502.22	3,514.37	2,573.19

TDS Pharm Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

TDS Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TDS Pharm Co Ltd (XKRX:464280) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

253 Pangyo-ro, Pangyo Inno Valley, Building C, Room 403, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486

Website

https://www.tdspharm.com

TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.

TDS Pharm Co Headlines

No Headlines